Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
R&D Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+24.2%
5Y CAGR+18.5%
Year-over-Year Change
Research and development spending
3Y CAGR
+24.2%/yr
vs +10.7%/yr prior
5Y CAGR
+18.5%/yr
Recent acceleration
Acceleration
+13.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
8 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $5.85B | +11.8% |
| 2024 | $5.23B | +31.3% |
| 2023 | $3.99B | +30.5% |
| 2022 | $3.06B | +16.6% |
| 2021 | $2.62B | +4.9% |
| 2020 | $2.50B | +11.6% |
| 2019 | $2.24B | +9.9% |
| 2018 | $2.04B | +5.6% |
| 2017 | $1.93B | -0.9% |
| 2016 | $1.95B | - |